Technovalia announces interim safety results from vaccine phase 1 trial

Technovalia has announced the interim safety results of the ongoing phase 1 clinical trial evaluating COVIGEN, a DNA Covid-19 vaccine candidate, in

Related Keywords

Australia ,Westmead ,New South Wales ,Nicholas Wood ,Laurent Dapremont , ,Pharmajet Needle Free ,Associate Professor Nicholas Wood ,Sydney Children ,Hospital Westmead Clinical School ,